We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Virus Filters Developed for Biomedical Applications

By LabMedica International staff writers
Posted on 22 Jul 2009
Print article
In biomedicine and biotechnology, the smallest, complex, compound-sample quantities must be effectively processed. Microsystems with new mechanisms of action for pumping, filtering, and separating will manage this task with great efficiency in the future.

Providing viable evidence of viruses in human blood presently requires time- and labor-intensive biomolecular procedures. Established methods are particularly hard pushed to produce evidence when the viral burden is very low, as for example during a phase of therapy. This could soon change: while developing new types of micro-pumps without movable parts, scientists from the Fraunhofer Institute for Biomedical Engineering IBMT (St. Ingbert, Germany) came across an unexpected phenomenon: stable turbulence structures formed in the microscale pump channels.

The nano- and microparticles actually intended to verify the pump effect accumulated in large quantities in the channels. The vortex patterns completely filled the whole microchannel, creating a virtually 100% trap for the particles that followed the generated flow profile, although there is a very large cross-section to flow through. "The development of flow vortices is nothing unusual on the macroscopic scale. However, in microchannels the flow lines almost run in parallel,” explained Dr. Richard Stein from the IBMT. "The question, therefore, was, how is it possible for vortices to be formed from this, which were sufficiently stable and effective for the concentration of nanoparticles?”

Experiments were not successful in determining the parameters by which the filter effect could be systematically controlled. This is because in the pump mechanism examined, high-frequency electrical traveling waves propel the fluid into the microchannels, superimposing a large number of effects on one another.

"In order to understand the complex procedures, there was a clear need for a theoretical description. My task was to describe the surprising phenomenon and to make it controllable,” noted Dr. Stein. In his thesis "Mathematical modeling, analysis, and numerical simulation of electrothermally driven micropumps.”

Richard Stein succeeded in explaining the development of the vortex pattern. To this end, he had to factor in all the relevant processes--of an electrical, thermal, and hydrodynamic nature--in a three-dimensional model. The findings of the project explain the observed effects completely, so that now both effective micropumps and efficient particle filters can be developed and built for many biomedical applications.

Related Links:
Fraunhofer Institute for Biomedical Engineering IBMT



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Immunoassays and Calibrators
QMS Tacrolimus Immunoassays

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.